Ritedose Appoints Carolyn Berg as Vice President of Strategic Growth in Sterile BFS Expansion

For pharma companies outsourcing sterile ophthalmic and respiratory manufacturing, The Ritedose Corporation has signaled a deliberate push to deepen its commercial reach, appointing Carolyn Berg as Vice President of Strategic Growth effective September 10, 2026. The move positions the Columbia, S.C.-based CDMO to compete more aggressively for outsourcing contracts as demand for sterile Blow-Fill-Seal (BFS) unit-dose capacity continues to tighten across the sector.

Berg arrives with over 25 years of commercial experience spanning business development, portfolio strategy, and product commercialization. Most recently, she served as Vice President of Business Development for Catalent's inhaled drug delivery solutions, where she led global sales and commercial strategy for the inhalation platform. Earlier roles at Cipla, Teva Respiratory, and Merck round out a career concentrated in the same therapeutic categories Ritedose serves.

In her new role, Berg will be responsible for advancing Ritedose's commercial strategy, maintaining existing customer relationships, and identifying new partnership opportunities in inhalation and ophthalmic markets, with scope extending to future market expansions. Ritedose describes itself as the largest sterile BFS CDMO in the United States, supporting partners from pre-IND and CMC development through commercialization of branded and generic products.

For QA directors and regulatory affairs leads evaluating CDMO partnerships, the hire carries a practical signal: Ritedose is investing in the commercial infrastructure needed to support a broader client base, which typically precedes capacity additions or expanded service offerings. President and CEO Jody Chastain framed the appointment as part of a broader strategic investment in leadership, infrastructure, and capabilities ahead of the company's next growth phase.

Berg holds bachelor's degrees in Journalism/Public Relations and French from the University of Texas at Austin and an International MBA from the Darla Moore School of Business at the University of South Carolina.

How quickly Berg converts commercial intent into contracted capacity will be a measurable indicator of whether Ritedose's BFS platform scales to meet the outsourcing demand its leadership is now structured to pursue.

Source: The Ritedose Corporation via GlobeNewswire, September 10, 2026.